BioWorld

July 8, 2002

View Archived Issues

Immunex Starts Second Phase III Study Of Enbrel For Psoriasis

Immunex Corp. said at the 20th annual World Congress of Dermatology Meeting in Paris that it began a second Phase III trial of Enbrel in psoriasis as the company seeks its fifth approval for the drug. (BioWorld Today) Read More

TransMolecular Fighting Cancer With The Help Of Scorpion Toxin

Read More

To Quell HIV's Inexorable Strain Variability, Alamos Lab Proposes Country-Defined AIDS Vaccines

Read More

Gerberding Named Director Of Centers For Disease Control

Read More

Holiday Notice

Read More

VaxGen, Genentech Revise Agreement On AIDS Vaccine

Read More

Other News To Note

Read More

Appointments And Advancements

Read More